The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus

The Journal of Lipid Research ◽

10.1194/jlr.m500387-jlr200 ◽

2005 ◽

Vol 47 (1) ◽

pp. 193-200 ◽

Author(s):

William L. Isley ◽

John M. Miles ◽

Bruce W. Patterson ◽

William S. Harris

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

High Dose ◽

Triglyceride Rich Lipoprotein

Download Full-text

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Dose Combination

Download Full-text

A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

European Heart Journal ◽

10.1093/eurheartj/ehq494 ◽

2011 ◽

Vol 32 (7) ◽

pp. 838-846 ◽

Author(s):

D. J. Angiolillo ◽

J. J. Badimon ◽

J. F. Saucedo ◽

A. L. Frelinger ◽

A. D. Michelson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Coronary Artery Disease ◽

Type 2 Diabetes Mellitus ◽

Coronary Artery ◽

High Dose ◽

Anti Platelet Therapy ◽

Download Full-text

Effects of Peroxisome Proliferator-Activated Receptors on Lipoprotein Metabolism and Glucose Control in Type 2 Diabetes Mellitus

The American Journal of Cardiology ◽

10.1016/j.amjcard.2006.11.010 ◽

2007 ◽

Vol 99 (4) ◽

pp. 96-104 ◽

Author(s):

Robert S. Rosenson

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glucose Control ◽

Lipoprotein Metabolism ◽

Peroxisome Proliferator ◽

Peroxisome Proliferator Activated Receptors

Download Full-text

Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea

Diabetes & Metabolism Journal ◽

10.4093/dmj.2017.41.4.275 ◽

2017 ◽

Vol 41 (4) ◽

pp. 275 ◽

Author(s):

Sol Jae Lee ◽

Su Jin Jeong ◽

Yu Chang Lee ◽

Yong Hoon Lee ◽

Jung Eun Lee ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Heart Rate Variability ◽

Type 2 Diabetes Mellitus ◽

Autonomic Neuropathy ◽

Lipoic Acid ◽

Cardiac Autonomic Neuropathy ◽

Download Full-text

Response: Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea (Diabetes Metab J 2017;41:275-83)

Diabetes & Metabolism Journal ◽

10.4093/dmj.2017.41.5.420 ◽

2017 ◽

Vol 41 (5) ◽

pp. 420

Author(s):

Chong Hwa Kim ◽

Sol Jae Lee ◽

Bong Yun Cha

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Heart Rate Variability ◽

Type 2 Diabetes Mellitus ◽

Autonomic Neuropathy ◽

Lipoic Acid ◽

Cardiac Autonomic Neuropathy ◽

Download Full-text

The role of lipoprotein metabolism and inflammatory gene polymorphims on the coronary artery disease with type 2 diabetes mellitus

Atherosclerosis ◽

10.1016/j.atherosclerosis.2018.06.315 ◽

2018 ◽

Vol 275 ◽

pp. e112-e113

Author(s):

N. Coban ◽

A.S. Ozuynuk ◽

A.F. Erkan ◽

B. Ekici ◽

E. Vurgun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Coronary Artery Disease ◽

Type 2 Diabetes Mellitus ◽

Coronary Artery ◽

Lipoprotein Metabolism ◽

Inflammatory Gene ◽

Download Full-text

Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies

10.1016/j.metabol.2006.02.014 ◽

2006 ◽

Vol 55 (7) ◽

pp. 879-884 ◽

Author(s):

Toshiyuki Hayashi ◽

Tsutomu Hirano ◽

Takeshi Yamamoto ◽

Yasuki Ito ◽

Mitsuru Adachi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Therapy ◽

Intensive Insulin Therapy ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

Low Density ◽

Triglyceride Rich Lipoprotein

Download Full-text

Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

Journal of Clinical Investigation ◽

10.1172/jci200523219 ◽

2005 ◽

Vol 115 (5) ◽

pp. 1323-1332 ◽

Author(s):

Kazunori Nagashima ◽

Carlos Lopez ◽

Daniel Donovan ◽

Colleen Ngai ◽

Nelson Fontanez ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoprotein Metabolism ◽

Download Full-text

The effect of low and high dose empagliflozin on HbA1c and lipid profile in Type 2 Diabetes mellitus: A real world data

Northern Clinics of Istanbul ◽

10.14744/nci.2019.22697 ◽

2019 ◽

Author(s):

Serhat Özçelik

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipid Profile ◽

High Dose ◽

Real World Data ◽

Download Full-text

Apolipoprotein A5 gene polymorphism –1131T→C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm.2005.105 ◽

2005 ◽

Vol 43 (6) ◽

Author(s):

Sheng-Kai Yan ◽

Xin-Qi Cheng ◽

Yao-Hong Song ◽

Xin-Hua Xiao ◽

Nan Bi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Coronary Heart Disease ◽

Type 2 Diabetes Mellitus ◽

Heart Disease ◽

Plasma Lipids ◽

Lipoprotein Metabolism ◽

Apolipoprotein A5 ◽

AbstractType 2 diabetes mellitus (DM) is associated with significant abnormalities of lipoprotein metabolism and coronary heart disease (CHD). The most commonly recognized lipid abnormality in type 2 DM is hypertriglyceridemia, which is known to be an independent risk factor for CHD in diabetics. The –1131T→C polymorphism found in the newly identified apoli-poprotein A5 (

Download Full-text